About Us

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, gastric cancer and glioblastoma.

External Links


Team Members

Frank Mercado (2)

Frank Mercado

Associate Medical Science Liaison

(Novocure) Catherine Tempel Brami headshot

Catherine Tempel Brami

MRI Researcher

(Novocure) Meghan Bloom_headshot

Meghan Bloom

Medical Affairs Fellow


Moshe Giladi

Senior Director of Preclinical Research